Your browser is no longer supported. Please, upgrade your browser.
PRGO Perrigo Company plc daily Stock Chart
Perrigo Company plc
IndexS&P 500 P/E41.73 EPS (ttm)1.77 Insider Own0.10% Shs Outstand138.10M Perf Week1.36%
Market Cap10.20B Forward P/E14.00 EPS next Y5.28 Insider Trans294.86% Shs Float136.48M Perf Month1.21%
Income249.80M PEG8.35 EPS next Q1.02 Inst Own86.70% Short Float6.77% Perf Quarter-2.58%
Sales4.92B P/S2.07 EPS this Y103.40% Inst Trans1.13% Short Ratio6.10 Perf Half Y-10.71%
Book/sh42.70 P/B1.73 EPS next Y8.65% ROA2.00% Target Price80.58 Perf Year-16.61%
Cash/sh3.83 P/C19.30 EPS next 5Y5.00% ROE3.90% 52W Range67.53 - 95.93 Perf YTD-15.25%
Dividend0.76 P/FCF21.00 EPS past 5Y-27.40% ROI3.30% 52W High-23.00% Beta0.69
Dividend %1.03% Quick Ratio1.20 Sales past 5Y6.90% Gross Margin40.10% 52W Low9.39% ATR2.06
Employees10400 Current Ratio1.80 Sales Q/Q-4.20% Oper. Margin11.60% RSI (14)55.50 Volatility3.27% 2.65%
OptionableYes Debt/Eq0.56 EPS Q/Q153.70% Profit Margin4.80% Rel Volume0.85 Prev Close72.75
ShortableYes LT Debt/Eq0.52 EarningsNov 08 BMO Payout42.00% Avg Volume1.51M Price73.87
Recom2.70 SMA202.61% SMA500.85% SMA200-6.76% Volume1,288,551 Change1.54%
Aug-10-18Reiterated Stifel Hold $92 → $87
Jul-30-18Downgrade Argus Buy → Hold
Jul-12-18Downgrade Goldman Neutral → Sell
Jan-03-18Initiated Leerink Partners Mkt Perform $90
Dec-08-17Upgrade Argus Hold → Buy
Nov-10-17Upgrade RBC Capital Mkts Underperform → Sector Perform $64 → $86
Oct-05-17Reiterated UBS Buy $84 → $98
Sep-07-17Initiated Oppenheimer Outperform $88
Aug-11-17Upgrade Goldman Sell → Neutral
Aug-11-17Reiterated RBC Capital Mkts Underperform $60 → $64
Jun-16-17Initiated Cantor Fitzgerald Overweight $85
Jun-05-17Downgrade RBC Capital Mkts Sector Perform → Underperform $66 → $60
Mar-03-17Reiterated B. Riley & Co. Neutral $83 → $67
Feb-28-17Reiterated Canaccord Genuity Buy $100 → $97
Feb-22-17Initiated Canaccord Genuity Buy $100
Jan-23-17Reiterated Jefferies Hold $84 → $70
Jan-17-17Reiterated RBC Capital Mkts Sector Perform $92 → $85
Nov-11-16Upgrade BofA/Merrill Underperform → Neutral
Nov-11-16Reiterated B. Riley & Co. Neutral $87 → $97
Aug-11-16Reiterated Barclays Overweight $120 → $110
Oct-17-18 12:48PM  What You Must Know About Perrigo Company plcs (NYSE:PRGO) Financial Strength Simply Wall St.
Oct-15-18 08:56AM  Perrigo Announces The Launch Of An AB Rated Generic Version Of Androgel® Topical Gel, 1.62% PR Newswire
Oct-09-18 11:30AM  [$$] The Future at Perrigo Is Brighter Than Investors Think The Wall Street Journal
10:27AM  Perrigo (PRGO) Hires Consumer Products Veteran as New CEO Zacks
09:16AM  [$$] Stocks to Watch: Alphabet, Exxon, Papa John's, Tesla The Wall Street Journal
06:44AM  Perrigo replaces CEO Roehrhoff with consumer goods veteran Reuters
06:37AM  Perrigo replaces CEO Roehrhoff with consumer goods veteran Reuters
Oct-08-18 09:41PM  [$$] Drugmaker Perrigo Hires a New CEO The Wall Street Journal
06:23PM  Perrigo replaces CEO Rohrhoff with consumer goods veteran Reuters
06:07PM  Perrigo Taps Tobacco Executive as CEO in Shift From Drugs Bloomberg
06:07PM  Perrigo replaces CEO Rohrhoff with consumer goods veteran Reuters
05:17PM  Perrigo appoints Murray Kessler as CEO MarketWatch
05:02PM  Perrigo Appoints Murray S. Kessler As President And Chief Executive Officer In Line With Shift To Consumer-Focused Strategy PR Newswire
Oct-01-18 10:24AM  Perrigo Confirms Patent Challenge for Generic Version of Jublia® Topical Solution 10% PR Newswire
Sep-28-18 09:00AM  Perrigo Announces Patent Litigation Settlement for the Generic Version of Picato® Gel PR Newswire
Sep-27-18 08:20AM  Analysis: Positioning to Benefit within Enerplus, ExlService, Gilead Sciences, 51job, QUALCOMM, and Perrigo Company plc Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Sep-19-18 09:00AM  Haeggquist & Eck, LLP is Investigating Claims Against Perrigos Directors and Officers for Breach of Fiduciary Duty Concerning Revenue Recognition for MS Pharmaceutical Tysabri Business Wire
Sep-17-18 10:38AM  Investors Are Undervaluing Perrigo Company plc (NYSE:PRGO) By 28.77% Simply Wall St.
Sep-10-18 09:36AM  Perrigo's OTC Version of Diarrhea Drug Imodium Gets FDA Nod Zacks
Sep-07-18 09:05AM  Perrigo Announces Final FDA Approval and Planned Launch for the Store Brand OTC Equivalent of Imodium® Multi-Symptom Relief PR Newswire
Aug-29-18 04:15PM  Perrigo to Reschedule Investor Event PR Newswire
Aug-27-18 05:54AM  Edited Transcript of PRGO earnings conference call or presentation 9-Aug-18 12:30pm GMT Thomson Reuters StreetEvents
Aug-22-18 02:25PM  Perrigo Company plc (NYSE:PRGO): Can It Deliver A Superior ROE To The Industry? Simply Wall St.
Aug-21-18 08:00AM  Today's Research Reports on Trending Tickers: Mallinckrodt and Perrigo Company ACCESSWIRE
Aug-20-18 08:00AM  Today's Research Reports on Trending Tickers: Arrowhead Pharmaceuticals and Perrigo Company ACCESSWIRE
Aug-10-18 11:11AM  Perrigo Needs 'Meet-Or-Beat' Quarters, Deutsche Bank Says In Downgrade Benzinga
Aug-09-18 07:46PM  [$$] Perrigo to Separate Its Prescription Pharmaceutical Business The Wall Street Journal -10.56%
05:57PM  Perrigo Company plc -- Moody's says Perrigo's ratings unaffected following announced separation of prescription business Moody's
05:06PM  [$$] Perrigo to Separate Its Prescription Pharmaceutical Business The Wall Street Journal
02:46PM  Mylan, Perrigo Earnings: Look Out Below!
02:08PM  Generic Drugmakers Struggle Despite U.S. Push for Copycats Bloomberg
10:35AM  Perrigo plans to separate prescription pharma business Reuters
09:48AM  Perrigo (PRGO) Beats on Q2 Earnings, Cuts View, Shares Down Zacks
08:48AM  Perrigo stock drops 6.5% after Q2 revenue miss, guidance cuts; company plans to separate drug unit MarketWatch
07:54AM  Stocks making the biggest moves premarket: VIAB, TRCO, BKNG, PRTY & more CNBC
07:30AM  Perrigo (PRGO) Beats Q2 Earnings Estimates Zacks
06:30AM  Perrigo Co. Plc to Host Earnings Call ACCESSWIRE
05:02AM  Perrigo: 2Q Earnings Snapshot Associated Press
12:11AM  Perrigo Expands OTC Growth Strategy With Rx-To-OTC Switch Licensing For Nasonex® PR Newswire
12:07AM  Perrigo Announces Plan To Separate Prescription Pharmaceuticals Business PR Newswire
12:02AM  Perrigo Company plc Reports Second Quarter 2018 Financial Results PR Newswire
Aug-08-18 03:05PM  Perrigo's Q2 Earnings Preview Benzinga
09:18AM  Drug/Biotech Stock Q2 Earnings on Aug 9: PRGO, BDSI & More Zacks
08:41AM  What's in the Cards for Perrigo (PRGO) This Earnings Season? Zacks
Aug-01-18 08:44AM  Perrigo Announces Quarterly Dividend PR Newswire
Jul-26-18 08:23AM  Perrigo To Release Second Quarter Calendar Year 2018 Financial Results On August 9, 2018 PR Newswire
Jul-24-18 07:35AM  Complimentary Technical Snapshots on Aquinox Pharma and Three More Healthcare Stocks ACCESSWIRE
Jul-17-18 05:12PM  After the Bell: Dow Rises 56 Points as Stocks Keep Chugging Higher
Jul-12-18 03:21PM  Drug Makers Can't Cure Investor Impatience
10:28AM  Goldman Sachs Swaps Perrigo, Johnson & Johnson Ratings Benzinga
Jun-29-18 09:37PM  AbbVie, AndroGel partner owe $448 million in antitrust case -U.S. judge Reuters
Jun-25-18 11:07AM  Conviction of SAC's Martoma upheld despite jury instructions Reuters
Jun-22-18 01:52PM  Should You Buy Perrigo Company plc (NYSE:PRGO) Based On These Aspects? Simply Wall St.
Jun-08-18 01:19PM  Valeant Pharmaceuticals Intl Inc Has New Name But Same Problems InvestorPlace
Jun-06-18 11:41AM  Valeant & Perrigo: Buy One, Skip the Other
07:55AM  Report: Developing Opportunities within Silicon Motion Technology, Green Brick Partners, Alliance Resource Partners, Perrigo Company plc, Epizyme, and Landec Future Expectations, Projections Moving into 2018 GlobeNewswire
Jun-01-18 02:23PM  Perrigo Stock Is Just Bearish, Any Way You Look At It
07:30AM  Breakfast Technical Briefing on Johnson & Johnson and Three Other Additional Healthcare Stocks ACCESSWIRE
May-30-18 08:30AM  Perrigo to Present at the Jefferies 2018 Healthcare Conference PR Newswire
May-24-18 08:35AM  Perrigo Confirms Patent Challenge For Generic Version Of Sernivo® Spray, 0.05% PR Newswire
May-21-18 01:42PM  Starboard Value Buys $30.2 Million More in Perrigo Stock
May-20-18 04:21PM  Benzinga's Insider Buys Of The Week: JPMorgan, Philip Morris And More Benzinga
May-17-18 04:35PM  Is There An Opportunity With Perrigo Company plcs (NYSE:PRGO) 30% Undervaluation? Simply Wall St.
May-16-18 07:29AM  Aspen's Infant Formula Unit Is Said to Draw Reckitt, Perrigo Bloomberg
May-14-18 04:55PM  Teva Pharma Spiked To Perrigo's Detriment On Asthma Inhaler Delay Investor's Business Daily
09:25AM  Perrigo Confirms First To File Patent Challenge For Generic Version Of Ultravate® Lotion, 0.05% PR Newswire
09:24AM  Stocks to Watch: Tesla, Alphabet, Xerox, Sears, Qualcomm, NXP, Walmart, JPMorgan, Ford, HP The Wall Street Journal
09:11AM  Morning Movers: Qualcomm, NXP Jump as China Restarts Merger Review, Perrigo Drops on Drug Review
May-11-18 05:07PM  Perrigo Drops After Saying FDA to Reject Inhaler, Delaying Start Bloomberg
05:02PM  [$$] FDA Rejects Perrigo's ProAir Generic, Drug Maker Says The Wall Street Journal
04:32PM  Perrigo no longer expects to get approval for generic Pro... CNBC Videos
04:30PM  Perrigo shares falls after company trims 2018 outlook MarketWatch
04:01PM  Perrigo Expects Complete Response Letter On Generic Version Of ProAir® PR Newswire
May-10-18 02:06PM  Edited Transcript of PRGO earnings conference call or presentation 8-May-18 12:30pm GMT Thomson Reuters StreetEvents
May-08-18 03:52PM  Perrigo (PRGO) Misses on Earnings in Q1, Reiterates View Zacks
10:43AM  Valeant Upside, Shire Buyout Don't Rally Pharma Stocks
12:01AM  Perrigo Company plc Reports First Quarter 2018 Financial Results PR Newswire
May-03-18 09:41AM  Perrigo Announces Quarterly Dividend PR Newswire
May-02-18 11:28AM  Is a Beat in the Cards for Perrigo (PRGO) in Q1 Earnings? Zacks
Apr-27-18 06:50PM  Amneal And Impax Receive FTC Clearance For Business Combination PR Newswire
05:27PM  Amneal, Impax win U.S. deal approval with conditions Reuters
05:11PM  U.S. FTC requires Amneal and Impax to divest rights to 10 generic drugs Reuters
Apr-24-18 04:58PM  Generic drugmakers to face first charges in U.S. probe - Bbg Reuters
Apr-13-18 07:00AM  Free Post Earnings Research Report: Perrigo Co.'s Quarterly Earnings Increased 3.23% ACCESSWIRE
Apr-11-18 09:41AM  Perrigo Launches Novel Omeprazole Orally Disintegrating Tablet to Treat Frequent Heartburn PR Newswire
Apr-06-18 07:33AM  Impax Launches a Generic Version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%) PR Newswire
Apr-04-18 12:07PM  Is Perrigo Company plc (NYSE:PRGO) A Sell At Its Current PE Ratio? Simply Wall St.
Apr-02-18 02:54AM  Why Is Perrigo Company (PRGO) Up 4.7% Since Its Last Earnings Report? Zacks
Mar-29-18 11:39AM  A Detailed Review Of Starboard Value's Stock Portfolio Benzinga
Mar-26-18 07:05AM  Sol-Gel Technologies Reports Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire
Mar-23-18 01:48PM  Will Perrigo Company plc (NYSE:PRGO) Continue To Underperform Its Industry? Simply Wall St.
Mar-07-18 08:49AM  Perrigo Announces Final FDA Approval and Planned Launch for the Store Brand OTC Equivalent of Mucinex® DM Maximum Strength Extended Release Tablets PR Newswire
08:46AM  Perrigo to Present at Upcoming Investor Conferences PR Newswire
03:54AM  Edited Transcript of PRGO earnings conference call or presentation 2-Mar-18 1:30pm GMT Thomson Reuters StreetEvents
Mar-02-18 04:16PM  Perrigo shares rise more than 4%, snapping losing streak MarketWatch
12:12PM  Perrigo (PRGO) Surpassed Earnings in Q4, Revenues Down Y/Y Zacks
Mar-01-18 05:06PM  Perrigo Files Form 10-K With SEC; Will Host Fourth Quarter And Calendar Year 2017 Financial Results Conference Call On March 2, 2018 PR Newswire
05:04PM  Perrigo Company plc Reports Fourth Quarter & Calendar Year 2017 Financial Results PR Newswire
Feb-27-18 09:53AM  Perrigo (PRGO) Postpones Q4 Earnings Results, Shares Down Zacks -7.13%
01:07AM  Perrigo Company plc Reports Select Preliminary Unaudited Calendar Year 2017 Financial Results PR Newswire
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments. It offers OTC products in cough, cold, allergy, sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic, lifestyle, personal care and derma-therapeutics, natural health and vitamins, and anti-parasite categories. The company also develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. The company offers its products through retail drug, supermarket, and mass merchandise chains; hospitals; pharmacies; wholesalers; drug and grocery stores; and para pharmacies, as well as through a network of pharmacy sales force in North America, Europe, Australia, Israel, and China. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Andersen SvendEVP & President CHCIAug 14Buy69.437,200499,8967,200Aug 16 03:30 PM
Winowiecki RonaldCFOJul 23Option Exercise75.972,297174,5036,320Jul 24 01:36 PM
Weninger PaulEVP, Quality OperationsJun 29Option Exercise72.9173253,3704,486Jul 03 07:51 PM
Quinn GrainneEVP, Chief Medical OfficerJun 29Option Exercise72.9126219,1022,533Jul 03 07:49 PM
Janish Ronald CraigEVP, Global Op. & Supply ChainJun 29Option Exercise72.9182760,2972,562Jul 03 07:38 PM
Winowiecki RonaldCFOJun 29Option Exercise72.9181859,6404,257Jul 03 07:34 PM
Wesolowski JohnEVP, President RxJun 29Option Exercise72.9148135,0702,113Jul 03 07:30 PM
Samuels Theodore R. IIDirectorJun 06Option Exercise73.224,265312,2835,624Jun 08 05:22 PM
KINDLER JEFFREY BDirectorJun 06Option Exercise73.224,265312,2834,793Jun 08 05:20 PM
Parker Geoffrey M.DirectorJun 06Option Exercise73.224,265312,2835,277Jun 08 05:19 PM
Alford Bradley ADirectorJun 06Option Exercise73.224,265312,2834,796Jun 08 05:17 PM
CLASSON ROLF ADirectorJun 06Option Exercise73.224,265312,2834,265Jun 08 05:14 PM
Smith Jeffrey CDirectorJun 06Option Exercise73.224,265312,2834,793Jun 08 05:12 PM
BRLAS LAURIEDirectorJun 06Option Exercise73.225,331390,33617,888Jun 08 05:10 PM
COHEN GARY MDirectorJun 06Option Exercise73.224,265312,28319,312Jun 08 05:09 PM
Karaboutis AdrianaDirectorJun 06Option Exercise73.224,265312,2834,265Jun 08 05:08 PM
O'Connor DonalDirectorJun 06Option Exercise73.224,265312,2837,443Jun 08 05:05 PM
Smith Jeffrey CDirectorMay 17Buy75.8950,0003,794,6453,662,220May 17 09:03 PM
Smith Jeffrey CDirectorMay 16Buy75.83100,0007,582,6103,616,273May 17 09:03 PM
Smith Jeffrey CDirectorMay 15Buy75.21250,00018,802,0133,526,419May 17 09:03 PM
Roehrhoff UweCEOMar 05Buy81.857,500613,8637,500Mar 07 04:46 PM
Winowiecki RonaldInterim CFOMar 01Option Exercise79.571,776141,3163,957Mar 05 03:17 PM
Wesolowski JohnEVP, President RxMar 01Option Exercise79.571,03382,1961,963Mar 05 03:12 PM
KINGMA TODD WExecutive VP, General CounselDec 28Option Exercise87.272,571224,37119,565Dec 29 11:45 AM
KINGMA TODD WExecutive VP, General CounselDec 28Sale88.521,500132,78017,252Dec 29 11:45 AM
Winowiecki RonaldInterim CFODec 22Option Exercise87.0184673,6102,449Dec 27 04:35 PM
Wesolowski JohnEVP, President RxDec 15Option Exercise86.5032428,0261,033Dec 19 06:45 PM
Wesolowski JohnEVP, President RxDec 14Buy85.8070060,060709Dec 19 06:54 PM
Wesolowski JohnEVP, President RxDec 07Sale83.0945037,3909Dec 11 08:30 PM
Wesolowski JohnEVP, President RxNov 29Sale87.6516814,72580Nov 30 06:28 PM
Wesolowski JohnEVP, President RxNov 28Sale86.8622019,109248Nov 30 06:28 PM
Farrington ThomasEVP and CIONov 16Sale87.2621318,5852,937Nov 20 02:53 PM
HENDRICKSON JOHN TCEONov 03Option Exercise82.362,181179,6279,164Dec 14 06:48 PM
Farrington ThomasEVP and CIONov 03Option Exercise82.3662351,3103,347Nov 20 02:53 PM